Terms: = Leukemia AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Treatment
56 results:
1. Feasible diet and circadian interventions reduce in vivo progression of FLT3-ITD-positive acute myeloid leukemia.
Rodriguez M; Fekry B; Murphy B; Figueroa M; Cheng T; Raber M; Wartenberg L; Bell D; Triche L; Crawford K; Ma H; Allton K; Ahmed R; Tran J; Ranieri C; Konopleva M; Barton M; Nunez C; Eckel-Mahan K; Chandra J
Cancer Med; 2024 Jan; 13(2):e6949. PubMed ID: 38334474
[TBL] [Abstract] [Full Text] [Related]
2. Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
Conter V; Valsecchi MG; Cario G; Zimmermann M; Attarbaschi A; Stary J; Niggli F; Dalla Pozza L; Elitzur S; Silvestri D; Locatelli F; Möricke A; Engstler G; Smisek P; Bodmer N; Barbaric D; Izraeli S; Rizzari C; Boos J; Buldini B; Zucchetti M; von Stackelberg A; Matteo C; Lehrnbecher T; Lanvers-Kaminsky C; Cazzaniga G; Gruhn B; Biondi A; Schrappe M
J Clin Oncol; 2024 Mar; 42(8):915-926. PubMed ID: 38096462
[TBL] [Abstract] [Full Text] [Related]
3. Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic leukemia Treated with Ibrutinib: A Look at Racial Differences.
Barrientos JC; Ayed AO; Cha A; Du S; Fang B; Hall R; Marks SM; Peng E; Rhodes JM; Ryan K; Winters SB; Yeung PL; Hou JZ
Target Oncol; 2023 Sep; 18(5):727-734. PubMed ID: 37728835
[TBL] [Abstract] [Full Text] [Related]
4. Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The Netherlands.
Ector GICG; Geelen IGP; Dinmohamed AG; Hoogendoorn M; Westerweel PE; Hermens RPMG; Blijlevens NMA
Leuk Lymphoma; 2023 Feb; 64(2):424-432. PubMed ID: 36369821
[TBL] [Abstract] [Full Text] [Related]
5. The sellar region as presenting theater for hematologic malignancies-A 17-year single-center experience.
Pekic S; Stojanovic M; Manojlovic Gacic E; Antic D; Milojevic T; Milicevic M; Stanimirovic A; Doknic M; Miljic D; Banjalic S; Jovanovic M; Jemuovic Z; Nikolic Djurovic M; Grujicic D; Popovic V; Petakov М
Endocr J; 2022 Sep; 69(9):1079-1090. PubMed ID: 35400679
[TBL] [Abstract] [Full Text] [Related]
6. [Changes of Serum Complement C1q in Patients with Multiple Myeloma].
Gui CS; Liu SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):506-510. PubMed ID: 35395987
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes.
Zhu JY; Huang X; Fu Y; Wang Y; Zheng P; Liu Y; Han Z
Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 34580712
[TBL] [Abstract] [Full Text] [Related]
8. Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant.
Lindsay J; Othman J; Yong MK; Ritchie D; Chee L; Tay K; Tio SY; Kerridge I; Fay K; Stevenson W; Arthur C; Chen SC; Kong DCM; Greenwood M; Pergam SA; Liu C; Slavin MA
Transpl Infect Dis; 2021 Oct; 23(5):e13719. PubMed ID: 34453768
[TBL] [Abstract] [Full Text] [Related]
9. Leukemic stem cells shall be searched in the bone marrow before "tyrosine kinase inhibitor-discontinuation" in chronic myeloid leukemia.
Ilhan O; Narli Ozdemir Z; Dalva K; Arslan A; Okay Ozgeyik M; Ipek S; Saydam G; Haznedaroglu IC
Int J Lab Hematol; 2021 Oct; 43(5):1110-1116. PubMed ID: 33834631
[TBL] [Abstract] [Full Text] [Related]
10. Presentation acuity, induction mortality, and resource utilization in infants with acute leukemia.
Ibrahimova A; Winestone LE; Miller TP; Kettler K; Seif AE; Huang YS; Elgarten CW; Myers RM; Fisher BT; Aplenc R; Getz KD
Pediatr Blood Cancer; 2021 Jul; 68(7):e28940. PubMed ID: 33704911
[TBL] [Abstract] [Full Text] [Related]
11. A simplified CD34+ based preharvest prediction tool for HPC(A) collection.
Jacob RP; Walsh EM; Maslak PG; Giralt SA; Avecilla ST
Transfusion; 2021 May; 61(5):1525-1532. PubMed ID: 33694175
[TBL] [Abstract] [Full Text] [Related]
12. Novel prognostic genes and subclasses of acute myeloid leukemia revealed by survival analysis of gene expression data.
Lai Y; OuYang G; Sheng L; Zhang Y; Lai B; Zhou M
BMC Med Genomics; 2021 Feb; 14(1):39. PubMed ID: 33536020
[TBL] [Abstract] [Full Text] [Related]
13. [Efficacy and Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Monocytic leukemia Patients].
Pan WY; Li KX; Wu SJ; Zheng YL; Deng L; Huang R; Tu SF; Song CY; Li YH; Huang YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1859-1866. PubMed ID: 33283711
[TBL] [Abstract] [Full Text] [Related]
14. Targeted photoresponsive carbazole-coumarin and drug conjugates for efficient combination therapy in leukemia cancer cells.
Wang BY; Lin YC; Lai YT; Ou JY; Chang WW; Chu CC
Bioorg Chem; 2020 Jul; 100():103904. PubMed ID: 32413630
[TBL] [Abstract] [Full Text] [Related]
15. Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline treatment in Adult Patients With Acute Promyelocytic leukemia.
Yang S; Ma R; Yuan X; Jiang L; Shi J; Yang J; Lei P; Zang Y; Chen X; Zhang Y; Liu Z; Guo J; Zhang L; Zhu X; Zhu Z
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e382-e391. PubMed ID: 32336675
[TBL] [Abstract] [Full Text] [Related]
16. LPS induces ALOX5 promoter activation and 5-lipoxygenase expression in human monocytic cells.
Poirier SJ; Boudreau LH; Flamand N; Surette ME
Prostaglandins Leukot Essent Fatty Acids; 2020 Mar; 154():102078. PubMed ID: 32120263
[TBL] [Abstract] [Full Text] [Related]
17. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.
Berger E; Delpierre C; Despas F; Bertoli S; Bérard E; Bombarde O; Bories P; Sarry A; Laurent G; Récher C; Lamy S
BMC Cancer; 2019 Sep; 19(1):883. PubMed ID: 31488077
[TBL] [Abstract] [Full Text] [Related]
18. ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine.
Mehrvar N; Akbari ME; Rezvany MR; Abolghasemi H; Saberynejad J; Mehrvar A; Faranoush M; Keramatinia AA; Shekarriz-Foumani R; Movafagh A
Cell Mol Biol (Noisy-le-grand); 2019 Feb; 65(2):7-13. PubMed ID: 30860475
[TBL] [Abstract] [Full Text] [Related]
19. Outcome of pediatric non-Hodgkin lymphoma in Central America: A report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA).
Peña-Hernandez A; Ortiz R; Garrido C; Gomez-Garcia W; Fuentes-Alabi S; Martinez R; Metzger ML; Chantada GL; Ribeiro RC
Pediatr Blood Cancer; 2019 May; 66(5):e27621. PubMed ID: 30677231
[TBL] [Abstract] [Full Text] [Related]
20. The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia.
Vulaj V; Perissinotti AJ; Uebel JR; Nachar VR; Scappaticci GB; Crouch A; Bixby DL; Burke PW; Maillard I; Talpaz M; Marini BL
Leuk Res; 2018 Jul; 70():91-96. PubMed ID: 29908418
[TBL] [Abstract] [Full Text] [Related]
[Next]